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ABSTRACT 
Colorectal cancer (CRC) is the third most common cancer and the second leading cause of 
cancer related death in the United States. Colonoscopy and fecal immunochemistry testing are 
the primary recommended CRC screening modalities. The purpose of this study is to improve 
rates of CRC screening in Veterans and County hospital patients referred to gastroenterology 
fellow’s clinics. A total of 717 patients between the ages of 49 and 75 (mean 62.0 ± 6.5) were 
seen. Prior CRC screening was not done in 109 (15.2%) due to not being offered (73.4%) or 
declining (26.6%) screening. Patients who received prior CRC screening compared to no prior 
screening were older (mean age 62.3 ± 6.4 vs 60.3 ± 6.8, p=0.003), white race (88.6% vs 78.3%, 
p=0.027), and more likely to be Veterans patients (90.8% vs 77.5%, p<0.001). After 
systematically discussing options for screening with 78 of the 109 unscreened patients, 56 of 
them (71.8%) underwent screening with either colonoscopy (32) or FIT (24). Patients seen by 
fellows in their last year of training agreed to undergo screening more often than those seen by 
other fellows (100% vs 66.2%, p=0.033). Systematic discussions about both colonoscopy and 
FIT can improve overall rates of CRC screening. 
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INTRODUCTION 
Colorectal cancer (CRC) is the third most common cancer and the second leading cause of 
cancer related death in the United States.1,2 Colonoscopy is considered a cancer prevention test 
and is the most common CRC screening method used in the United States. It has been shown to 
decrease CRC incidence and CRC related mortality.3,4 Fecal immunochemical tests (FIT) is a 
sensitive and specific stool based test that detects human globin as a surrogate for advanced 
colorectal adenomas or cancer.5 Guidelines recommend that colonoscopy be performed as the 
preferred CRC prevention test due to its advantage of providing direct visualization of the colon 
while allowing endoscopists to perform polypectomy at the time of the exam, but annual FIT is 
considered a second preferred CRC detection test that provides patients with a non-invasive 
alternative.6,7 Despite the clear evidence that CRC screening is beneficial, its effectiveness is 
limited by underuse.8 Anecdotal experience suggests that patients older than 50 years of age 
referred to gastroenterologists are not always screened for CRC. 
 
Studies have shown that physicians feel more comfortable recommending colonoscopy over FIT 
as a CRC screening modality to their patients.9 Therefore, higher rates of patients undergoing 
colonoscopy compared to FIT might be a reflection of physician preference, not patient 
preference. Patient preference between colonoscopy and FIT is currently unknown. 
 
The primary aim of this study was to improve CRC screening in patients referred to 
gastroenterology (GI) fellow’s clinics. Additional aims included an assessment of patient 
preference between the primary recommended CRC screening modalities (colonoscopy or FIT) 
when GI fellows use a standardized approach to discuss CRC screening. 
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METHODS 
This is a prospective quality improvement study from October 2016 to February 2017. The main 
goal of this study was to improve CRC screening rates in average risk patients referred to GI 
fellows’ clinics located either at a local county hospital or a Veterans Administration Medical 
Center. Additional chart review and data collection was done retrospectively. As a quality 
improvement project, this study qualified for an IRB waiver. 
 
The study population included all patients aged 49 to 75 years old at the time of the clinic 
encounter who are considered average risk for CRC. Determination was made as to whether the 
patient had undergone prior CRC screening either by colonoscopy within 10 years or FIT within 
1 year of the clinic encounter. Exclusion criteria included patients at increased risk for CRC due 
to a family history of CRC and patients with a personal history of neoplastic polyps or CRC. 
Additionally, if patients required a colonoscopy for other diagnostic purposes as determined at 
the time of the clinic encounter, they were excluded. To minimize referral bias in patients who 
had symptoms suggestive of a colonic disorder, the included patients were seen for reasons 
unrelated to the colon, such as upper GI tract disease, liver disease, and pancreaticobiliary 
disease.  
 
Fellows conducted a standardized discussion with eligible patients, using a discussion guide and 
patient provided handout (Supplemental data, Appendix) to allow a consistent approach with all 
patients; the discussion included an explanation about both screening modalities and the 
importance of patient preference as to the preferred test. After a decision was made about CRC 
screening, the fellow then ordered the patient’s preferred test. If the patient continued to decline 
screening, note of this was made in the chart. Co-fellows were then assigned to review each 
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other’s charts and collect data retrospectively, including patient demographics, 
inclusion/exclusion criteria, history of prior CRC screening, reasons for declining CRC 
screening, and choice of screening modality. Data collection was done over 3 separate interim 
reviews each spanning 5 weeks, to ensure adherence to the quality improvement intervention and 
to provide feedback for improvement. 
 
Data analysis was performed using Statistical Package for Social Sciences (SPSS) version 21 
software (SPSS Inc., Chicago, IL, United States). Continuous variables are described as mean 
with standard deviation. Categorical variables are described as frequencies and proportions. Chi-
square test was used to compare categorical data. Student’s t-test was used to compare 
continuous variables. Statistics were considered statistically significant for p<0.05. 
 
RESULTS 
A total of 717 patients between the ages of 49 and 75 were seen over the course of the study with 
a mean (SD) age of 62.0 (6.5) and 215 (30.0%) female. As depicted in Figure 1, prior CRC 
screening was done in 608 patients (84.8%) with 597 (83.2%) undergoing colonoscopy within 10 
years of the encounter, 10 (1.4%) undergoing FIT within 1 year, and 1 (0.1%) undergoing both. 
Of the 109 patients who had not undergone prior CRC screening, the reasons for not screening 
included 80 (73.4% of 109 patients and 11.2% of the entire cohort) who were not offered CRC 
screening services and 29 (26.6% and 4.0% of the entire cohort) who declined screening. 
 
A flow diagram (Figure 2) demonstrates how the patients were ultimately included in the study. 
Of the 109 patients with no prior screening, 18 were excluded due to a need for diagnostic 
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colonoscopy and none were excluded due to a family history of CRC. An additional 13 patients 
did not have CRC screening addressed at the time of the clinic encounter. This resulted in 78 
patients without prior CRC screening who were included in the study. 
 
Table 1 demonstrates baseline characteristics of 717 patients seen in clinic. Patients who 
received prior CRC screening compared to no prior screening were older (mean age 62.3 ± 6.4 vs 
60.3 ± 6.8, p=0.003). A greater proportion of males compared to females had prior screening 
(86.9% vs 80%, p=0.019). A greater proportion of White compared to Black patients had prior 
screening (88.6% vs 78.3%, p=0.027). A greater proportion of Veterans patients compared to 
County patients had prior screening (90.8% vs 77.5%, p<0.001). Collection periods 1, 2, and 3 
had similar proportions of patients with prior screening (84.7%, 85.6%, vs 83.7%, p=0.836), 
suggesting that the population across these three periods were similar. 
 
Of the 78 included patients without prior screening, 56 (71.8%) agreed to undergo screening 
including colonoscopy in 32 and FIT in 24. Tables 2 and 3 demonstrate characteristics of patients 
who did not receive prior CRC screening. Table 2 compares patients who agreed to undergo 
screening to patients who declined screening. Age (60.3 ± 5.9 vs 60.6 ± 9.1, p=0.883) was 
similar between both groups. The proportion of males agreeing to undergo screening vs females 
was greater, although this approached but did not reach statistical significance (79.2% vs 60%, 
p=0.067). The proportion of White patients agreeing to undergo screening was similar to Black 
patients (51.0% vs 78.6%, p=0.187). Patients who were not previously offered screening agreed 
to undergo screening 75% (39/52) of the time. The proportion of patients that agreed to undergo 
CRC screening, who were not previously offered screening was similar to those who were 
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previously offered screening but declined (75% vs 65.4%, p=0.374). The proportion of patients 
at the county hospital clinic agreeing to undergo screening was similar to patients at the VA 
clinic (69.5% vs 78.9%, p=0.426). Patients seen by fellows in their 3rd year of training agreed to 
undergo screening more often than fellows in their 1st or 2nd years of training (100% vs 70.3% or 
60.7%, p=0.033). There were similar proportions of patients seen during collection period 1, 2, 
or 3 that agreed to undergo screening (75% vs 73.5% vs 66.7%, p=0.793). 
 
Table 3 compares patients who agreed to undergo screening via colonoscopy to patients who 
agreed to undergo screening via FIT. Age (60.3 ± 6.2 vs 60.4 ± 5.5, p=0.933) was similar 
between both groups. None of the following characteristics predict a choice of colonoscopy or 
FIT: gender (male 63.2% vs female 44.4%, p=0.186), race (White 52% vs Black 63.6%, 
p=0.351), reason for not previously undergoing screening (not offered 56.4% vs declined 58.8%, 
p=0.867), clinic location (county 61% vs VA 46.7%, p=0.338), fellow level of training (1st year 
57.7% vs 2nd year 47.1% vs 3rd year 69.2%, p=0.476), or collection period (1st period 46.7% vs 
2nd period 56% vs 3rd period 68.8%, p=0.457). 
 
Finally, when comparing patients who had screening prior to being seen in the gastroenterology 
clinic to patients who agreed to undergo screening after being seen, a greater proportion of 
patients who had been screened previously used colonoscopy as their first screen modality as 
opposed to FIT (597/608 (98.2%) vs 32/56 (57.1%), p<0.001). 
 
LIMITATIONS 
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There are several limitations to this study. This study is not generalizable to all patients since 
patients were seen at a local county hospital and a Veterans Administration Medical Center. 
Nevertheless, it was important to include the county hospital in this quality improvement 
initiative since this population of patients is underserved. Secondly, the study is not generalizable 
to all providers since the physicians offering colorectal cancer screening were all 
gastroenterology fellows. The lower rate of colorectal cancer screening in patients seen by less 
experienced fellows may have decreased the magnitude of effect of this study. On the other 
hand, gastroenterologists may have more experience discussing details about FIT or colonoscopy 
than general practitioners. Thirdly, the lack of difference seen in patients who underwent 
screening with FIT compared to colonoscopy is likely due to the study being underpowered to 
detect such differences. A larger study looking at all patient populations across several different 
types of practices and subspecialties should be done to address these limitations. Lastly, there 
may be referral bias since patients were seen at a gastroenterology clinic rather than a primary 
care clinic. We attempted to reduce this bias by excluding patients who were seen for symptoms 
that might be related to colonic disease that necessitated a diagnostic colonoscopy. 
 
DISCUSSION 
This study showed an 84.8% rate of colorectal cancer screening in a population of 717 patients 
between the ages of 49 and 75 referred to a gastroenterology fellow’s clinic. This is better than 
2013 national data demonstrating 61.2% of adults between the ages of 50 and 75 that were up-to-
date with CRC screening.10 This may reflect a referral bias as patients who come to clinic are 
more likely to be compliant with health care utilization. This also may reflect improvement in 
health care access since the Affordable Care Act was passed. Colonoscopy still remains the 
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screening modality of choice, as an overwhelming majority (98.2%) of patients who were 
screened, received colonoscopy. 
 
A significant percent of patients (11.2%) reported that they were never offered CRC screening. 
This number is concerning as these patients are typically referred to the gastroenterology clinic 
from their primary care physician, who should be the first line of providers referring patients for 
screening as well. This percent is also reflected in the 13 of 109 (11.9%) patients who missed an 
opportunity for CRC screening despite being seen in a gastroenterology clinic. This suggests that 
we all need to do better to ensure all patients seen in our clinics are given recommendations to 
undergo CRC screening. 
 
The baseline characteristics of patients who had undergone screening prior to being seen in the 
gastroenterology clinic show similar trends that are available nationally. Black patients11 and 
underserved populations12 (such as those seen at the county hospital clinic) are known to have 
lower rates of receiving CRC screening services, similar to this study. Older patients also tend to 
be screened more frequently in this data, which is not surprising since they had more eligible 
years of colorectal cancer screening and therefore more opportunity to undergo screening. Men 
also were more likely to be screened than women. It is unclear if this is a function of the 
populations in this study, as the Veterans population tends to be predominantly male and this is 
the population that is also more likely to undergo screening. 
 
Although several differences were noted in the baseline group of patients referred to the 
gastroenterology clinic, these differences were not seen in the intervention group of patients who 
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had not received prior colorectal screening. Patients in this study had systematic discussions 
about colorectal cancer screening. Age, comorbidity score, gender, race, and the county or VA 
clinic did not demonstrate discrepancies between patients who decided to undergo screening and 
patients who declined screening after these discussions. Although these factors, most notably 
race and socio-economic status, seem to play a role in the population as a whole, when 
physicians take the time to discuss colorectal cancer screening with patients, these factors 
become less important. 
 
In this study, men agreed to undergo colorectal screening more frequently than women, as this 
approached but did not reach statistical significance. It is unclear why women tended to decline 
CRC screening at higher rates. However, the consequence of this is likely attenuated as men 
have been previously shown to have a higher risk of advanced adenomas during screening 
colonoscopies.13,14 
 
One important observation is that 75% of patients who previously declined CRC screening 
agreed to undergo screening after being seen by a gastroenterology fellow. This study 
demonstrates that a systematic approach to offering both colonoscopy and FIT can change 
patient’s minds about screening. A prior randomized controlled trial comparing patients who 
were offered colonoscopy to patients who were offered either colonoscopy or fecal occult blood 
testing (FOBT) demonstrated that offering both colonoscopy and non-invasive testing improves 
screening rates.15 Although physicians feel more comfortable recommending colonoscopy9, a 
better job needs to be done in discussing non-invasive alternative options to improve rates of 
CRC screening. 
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This study demonstrated that patients seen by 3rd year fellows have higher rates of undergoing 
CRC screening compared to patients seen by 2nd year and 1st year fellows. This suggests that 
having a discussion with more experienced gastroenterologists can further improve rates of CRC 
screening. It is unclear whether this improvement is due to more years of training overall, or 
specifically more years of training in the field of gastroenterology. A study looking at rates of 
CRC screening in patients who have undergone discussions with either experienced internists or 
experienced gastroenterologists may answer this question. Furthermore, a larger study that 
includes more fellows from multiple institutions would need to be done to confirm these 
findings. 
 
There were no differences in the characteristics of patients who agreed to undergo screening via 
colonoscopy compared to patients who agreed to undergo screening via FIT after a discussion in 
GI clinic. A larger study is likely needed to detect differences. Additionally, focus groups 
assessing the attitude of patients around the screening modalities may shed light on this topic. 
However, patients who had been screened previously were more likely to be screened by 
colonoscopy rather than FIT when compared to patients who agreed to undergo screening after a 
systematic discussion about both options. Although we were not able to study this directly, we 
suspect this difference is because patients only had colonoscopy previously offered to them. To 
improve Healthcare Effectiveness Data and Information Set (HEDIS) measures in primary care 
providers’ clinics, we recommend that they be comfortable discussing alternative screening 
modalities with patients if colonoscopy is declined. 
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CONCLUSIONS 
This study demonstrated that 15% of eligible patients referred to a gastroenterology clinic had 
not previously undergone colorectal cancer screening. Older age, male gender, White race, and 
higher socioeconomic class is associated with higher rates of screening. However, when patients 
have systematic discussions about colonoscopy and FIT testing with a gastroenterology fellow, 
these differences are not seen. Discussions with a more experienced gastroenterology fellow may 
improve overall rates of screening.  
 
IMPLICATIONS 
Systematic discussions about both colonoscopy and the non-invasive FIT option likely improve 
overall rates of screening and may increase rates of utilizing FIT testing relative to colonoscopy 
for colorectal cancer screening. Further study is needed to see if these discussions will improve 
rates of colorectal cancer screening in additional populations.  
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Figure 1. Prior CRC screening in patients referred to GI clinic. 
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Figure 2. Flow diagram of patients included in the study. 
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Supplemental Digital Content 
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Table 1. Baseline characteristics of 717 patients between the ages of 49 and 75 seen in GI 
clinic. 
 Entire population 
(n=717) 
Prior screening 
(n=608) 
No prior screening 
(n=109) 
p-value 
Age, mean ± SD 62.0 ± 6.5 62.3 ± 6.4 60.3 ± 6.8 0.003 
Charlson score 2.0 ± 1.5 2.1 ± 1.5 1.7 ± 1.3 0.021 
Gender, n (%) 
 Female 
 Male 
 
215/717 (30.0%) 
502 (70.0%) 
 
172/717 (80%) 
436 (86.9%) 
 
43 (20%) 
66 (13.1%) 
0.019 
Race, n (%) 
 White 
 Black 
 Hispanic 
 Asian 
 Other 
 
428/717 (65.8%) 
175 (24.4%) 
29 (4.0%) 
4 (0.6%) 
14 (2.0%) 
 
379/428 (88.6%) 
137 (78.3%) 
25 (86.2%) 
3 (75%) 
12 (85.7%) 
 
49 (11.4%) 
38 (21.7%) 
4 (13.8%) 
1 (25%) 
2 (14.3%) 
0.027 
Population, n (%) 
 County 
 Veterans 
 
325/717 (45.3%) 
392 (54.7%) 
 
252/325 (77.5%) 
356 (90.8%) 
 
73 (22.5 %) 
36 (9.2%) 
<0.001 
Collection period 
 1 
 2 
 3 
 
216/717 (30.1%) 
299 (41.7%) 
202 (28.2%) 
 
183/216 (84.7%) 
256 (85.6%) 
169 (83.7%) 
 
33 (15.3%) 
43 (14.0%) 
33 (16.3%) 
0.836 
 
 
Table 2. Comparison of patients who agreed to undergo CRC screening vs those who 
declined screening. 
 Agree to screen 
(n=56) 
Declined 
(n=22) 
p-value 
Age, mean ± SD 60.3 ± 5.9 60.6 ± 9.1 0.883 
Charlson score 1.7 ± 1.4 2.1 ± 1.3 0.160 
Gender, n (%) 
 Female (n=30) 
 Male (n=48) 
 
18/30 (60%) 
38 (79.2%) 
 
12 (40%) 
10 (20.8%) 
0.067 
Race, n (%) 
 White (n=33) 
 Black (n=28) 
 Hispanic (n=3) 
 Asian (n=1) 
 Other (n=1) 
 
25/33 (51.0%) 
22 (78.6%) 
2 (66.7%) 
0 
0 
 
8 (24.2%) 
6 (21.4%) 
1 (33.3%) 
1 
1 
0.187 
Reason not screened, n (%) 
 Not offered (n=52) 
 Previously declined (n=26) 
 
39/52 (75%) 
17 (65.4%) 
 
13 (25%) 
9 (34.6%) 
0.374 
Population, n (%) 
 County (n=59) 
 Veterans (n=19) 
 
41/69 (69.5%) 
15 (78.9%) 
 
18 (30.5%) 
4 (21.1%) 
0.426 
Fellow by year, n (%) 
 1 (n=37) 
 2 (n=28) 
 3 (n=13) 
 
26/37 (70.3%) 
17 (60.7%) 
13 (100%) 
 
11 (29.7%) 
11 (39.3%) 
0 
0.033 
Collection period, n (%) 
 1 (n=20) 
 2 (n=34) 
 3 (n=24) 
 
15/20 (75%) 
25 (73.5%) 
16 (66.7%) 
 
5 (25%) 
9 (26.5%) 
8 (33.3%) 
0.793 
 
 
Table 3. Comparison of patients who agreed to undergo CRC screening with colonoscopy 
vs FIT. 
 Colonoscopy 
(n=32) 
FIT 
(n=24) 
p-value 
Age, mean ± SD 60.3 ± 6.2 60.4 ± 5.5 0.933 
Charlson score 1.5 ± 1.4 1.8 ± 1.2 0.547 
Gender, n (%) 
 Female (n=18) 
 Male (n=38) 
 
8/18 (44.4%) 
24/38 (63.2%) 
 
10 (55.6%) 
14 (36.8%) 
0.186 
Race, n (%) 
 White (n=25) 
 Black (n=22) 
 Hispanic (n=2) 
 
13/25 (52%) 
14 (63.6%) 
2 (100%) 
 
12/20 (48%) 
8 (36.4%) 
0 
0.351 
Reason not screened, n (%) 
 Not offered (n=39) 
 Previously declined (n=17) 
 
22/39 (56.4%) 
10 (58.8%) 
 
17 (43.6%) 
7 (41.2%) 
0.867 
Population, n (%) 
 County (n=41) 
 Veterans (n=15) 
 
25/41 (61.0%) 
7 (46.7%) 
 
16 (39.0%) 
8 (53.3%) 
0.338 
Fellow by year, n (%) 
 1 (n=26) 
 2 (n=17) 
 3 (n=13) 
 
15/26 (57.7%) 
8 (47.1%) 
9 (69.2%) 
 
11 (42.38%) 
9 (52.9%) 
4 (30.8%) 
0.476 
Collection period, n (%) 
 1 (n=15) 
 2 (n=25) 
 3 (n=16) 
 
7/15 (46.7%) 
14 (56%) 
11 (68.8%) 
 
8 (53.3%) 
11 (44%) 
5 (31.3%) 
0.457 
 
 
 


